Section Arrow
TOVX.NYSE-M
- Theriva Biologics Inc
Quotes are at least 15-min delayed:2025/11/15 09:23 EST
Regular Hours
Last
 0.2713
-0.0037 (-1.35%)
Day High 
0.2808 
Prev. Close
0.275 
1-M High
0.8632 
Volume 
1.61M 
Bid
0.2607
Ask
0.2699
Day Low
0.2624 
Open
0.271 
1-M Low
0.262201 
Market Cap 
9.28M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.29 
20-SMA 0.31 
50-SMA 0.38 
52-W High 2.08 
52-W Low 0.262201 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-4.22/-0.75
Enterprise Value
10.24M
Balance Sheet
Book Value Per Share
0.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed:2025/11/15 09:23 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.